X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Lupin Ltd with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

LUPIN LTD vs TEVA PHARMA (Israel) - Comparison Results

LUPIN LTD    Change

Lupin is a leading pharmaceutical company with a strong presence in anti-infective, cardiovascular and asthma. Apart from having a strong domestic presence, the company markets its products in the regulated markets of the US and Europe and semi-regul... More

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 LUPIN LTD   TEVA PHARMA
EQUITY SHARE DATA
    LUPIN LTD
Mar-17
TEVA PHARMA
Dec-13
LUPIN LTD/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs1,7502,664-   
Low Rs1,3842,314-   
Sales per share (Unadj.) Rs387.41,528.8-  
Earnings per share (Unadj.) Rs56.695.5-  
Cash flow per share (Unadj.) Rs76.8219.1-  
Dividends per share (Unadj.) Rs7.5083.60-  
Dividend yield (eoy) %0.53.4 14.3%  
Book value per share (Unadj.) Rs298.91,698.2-  
Shares outstanding (eoy) m451.58848.00-   
Bonus/Rights/Conversions ESOPS--  
Price / Sales ratio x4.01.6 248.4%   
Avg P/E ratio x27.726.1 106.2%  
P/CF ratio (eoy) x20.411.4 179.5%  
Price / Book Value ratio x5.21.5 357.6%  
Dividend payout %13.287.5 15.1%   
Avg Mkt Cap Rs m707,5132,110,655 33.5%   
No. of employees `00016.844.9 37.4%   
Total wages/salary Rs m28,4950-   
Avg. sales/employee Rs Th10,418.328,845.0 36.1%   
Avg. wages/employee Rs Th1,697.00-   
Avg. net profit/employee Rs Th1,523.01,801.9 84.5%   
INCOME DATA
Net Sales Rs m174,9431,296,439 13.5%  
Other income Rs m1,0650-   
Total revenues Rs m176,0081,296,439 13.6%   
Gross profit Rs m44,931355,031 12.7%  
Depreciation Rs m9,122104,792 8.7%   
Interest Rs m1,52525,464 6.0%   
Profit before tax Rs m35,349224,774 15.7%   
Minority Interest Rs m-721,021 -7.0%   
Prior Period Items Rs m830-   
Extraordinary Inc (Exp) Rs m0-147,552 0.0%   
Tax Rs m9,785-2,744 -356.6%   
Profit after tax Rs m25,57580,988 31.6%  
Gross profit margin %25.727.4 93.8%  
Effective tax rate %27.7-1.2 -2,267.3%   
Net profit margin %14.66.2 234.0%  
BALANCE SHEET DATA
Current assets Rs m119,542875,610 13.7%   
Current liabilities Rs m61,206763,606 8.0%   
Net working cap to sales %33.38.6 386.0%  
Current ratio x2.01.1 170.3%  
Inventory Days Days7691 83.7%  
Debtors Days Days9096 93.7%  
Net fixed assets Rs m131,660423,446 31.1%   
Share capital Rs m9033,191 28.3%   
"Free" reserves Rs m134,0730-   
Net worth Rs m134,9761,440,098 9.4%   
Long term debt Rs m56,478662,898 8.5%   
Total assets Rs m266,0732,962,780 9.0%  
Interest coverage x24.29.8 246.0%   
Debt to equity ratio x0.40.5 90.9%  
Sales to assets ratio x0.70.4 150.3%   
Return on assets %10.23.6 283.5%  
Return on equity %18.95.6 336.9%  
Return on capital %19.34.9 390.7%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m60,3780-   
CASH FLOW
From Operations Rs m41,148206,585 19.9%  
From Investments Rs m-25,287-73,202 34.5%  
From Financial Activity Rs m4,332-247,813 -1.7%  
Net Cashflow Rs m20,193-114,429 -17.6%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 63.82 Rs / USD

Compare LUPIN LTD With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  

Compare LUPIN LTD With: J.B.CHEMICALS  ELDER PHARMA  AUROBINDO PHARMA  GSK PHARMA  ORCHID PHARMA LTD  



Today's Market

Sensex Hits 36,000-Mark; Infosys & Tata Steel Top Gainers(09:30 am)

Asian equities are higher today as Chinese and Hong Kong shares show gains. The Shanghai Composite is up 0.82% while the Hang Seng is up 1.26%. The Nikkei 225 is trading up by 0.93%.

Related Views On News

Lupin: US Markets Drags down Revenues and Net Profits (Quarterly Results Update - Detailed)

Nov 2, 2017

Domestic markets registers robust growth in the quarter

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Lupin: Decline in US Business Impacts Overall Growth (Quarterly Results Update - Detailed)

May 29, 2017

Currency fluctuation and one time provision impacts operating margins.

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

More Views on News

Most Popular

Mutual Funds Clearly Tell Us That There is a Bubble in the Stock Market(Vivek Kaul's Diary)

Jan 11, 2018

The maximum amount of money ever has come into equity mutual funds during the current financial year.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Nirvana denied: Has Value Failed?(The Honest Truth)

Jan 13, 2018

Should investors choose growth over value this year?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

LUPIN LTD SHARE PRICE


Jan 23, 2018 11:11 AM

TRACK LUPIN LTD

  • Track your investment in LUPIN LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

LUPIN LTD 8-QTR ANALYSIS

COMPARE LUPIN LTD WITH

MARKET STATS